Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3894PDF: 1674HTML: 874Figures . Eliassian: 276 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1432PDF: 497HTML: 18633Figure 1: 202Figure 2: 186Figure 3: 198Figure 4: 231Figure 5: 206 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1146PDF: 977Suppl. Files: 625HTML: 110 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1606PDF: 954HTML: 1024figures: 227table 1: 227table2: 231table3: 231 -
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
3582PDF: 1105HTML: 1046Figure 1: 235 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7927PDF: 2509HTML: 2142Table 1.: 269Table 2.: 277Table 3.: 259Table 4.: 256 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1293PDF: 616HTML: 274 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2740PDF: 1101HTML: 5124Cover Letter: 198Figure 2: 206Figure 1: 210Figure 3: 234Figure 4: 208Figure Legend: 217Table 1: 236Table 2: 218Table 3: 215 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1643PDF: 829HTML: 2206Untitled: 262Untitled: 240Untitled: 236Untitled: 252Untitled: 249 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2577PDF: 946HTML: 2579 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1989PDF: 734HTML: 2438Untitled: 198Figure 1 a: 198Figure 1 b: 211Fig 1 c: 192Figure 1 d: 241 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2409PDF: 2144HTML: 233 -
Simultaneous dual pathology in lymph node
1732PDF: 756HTML: 7850Simultaneous dual pathology in lymph node: 211Simultaneous dual pathology in lymph node: 220Simultaneous dual pathology in lymph node: 183Simultaneous dual pathology in lymph node: 227Simultaneous dual pathology in lymph node: 219 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3414PDF: 997HTML: 3878 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1504PDF: 504HTML: 293 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
4188PDF: 1172HTML: 919 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1294PDF: 641HTML: 6935 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2230PDF: 901HTML: 370 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1984PDF: 859HTML: 255 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3902PDF: 1705HTML: 104 -
Pathologic splenic rupture in a patient with follicular lymphoma
1495PDF: 606HTML: 1226rupture: 219 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2481PDF: 1060HTML: 1670Fig 1: 232Tab I: 253Cover Letter: 255 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2639PDF: 896HTML: 9066Efremov 1: 269Efremov 2: 237 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2434PDF: 1384HTML: 17214Bassan Fig.1: 176Bassan Fig.2: 282Bassan Fig.4: 168Fig.3: 251







